Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Apr 15, 2021 8:46am
65 Views
Post# 32999210

After wiping out retail investors they kept a loan of

After wiping out retail investors they kept a loan of10 million  why because they put covenants against it.    During 2019 sartore confirmed this but didn't want to tell investors    Are all ip/patents plus what else did they put as guarantee against a small 10 million loan from salp/thomvest  MORE PROOF THEY WANTED TO PREVENT RETAIL INVESTORS FROM BENEFITING FROM ASSETS PROMETIC AS 

listen to agm audio the q&a 2019 
<< Previous
Bullboard Posts
Next >>